Journal profile

Inflammation and Cell Signaling

ISSN 2330-7803 · Smart Science & Technology LLC · United States

Inflammation and Cell Signaling: fully open access; APC about USD 1,280; review about 6 weeks (community reports); 0 articles in 2025.

The latest issue on the journal's website is from 2024 (Volume 11): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 6 weeksCommunity average
APCUSD 1,280Fully open access
Acceptance—No reports yet
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

Inflammation and Cell Signaling is published by Smart Science & Technology LLC. By OpenAlex counts of its recent articles, its largest topics are Immune Response and Inflammation, Neuroinflammation and Neurodegeneration Mechanisms and Adipokines, Inflammation, and Metabolic Diseases, together about 25.8% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)

Inflammation and Cell Signaling (Electronic ISSN 2330-7803) is an open access, peer-reviewed, online journal publishing articles of the highest quality pertaining to all aspects of inflammation and associated signal transduction pathways in normal and pathological conditions. The editorial office of this journal is based at and sponsored by Guizhou Provincial People's Hospital Affiliated to Guizhou University.

From the journal's Aims & Scope

Editor-in-chief Current Archives COVIDPublisher website

Editorial board by country: 6 in mainland China (about 67%); most named Mainland China 6, United States 2, Sweden 1 (9 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Immune Response and InflammationImmunology and Microbiology11%
  2. Neuroinflammation and Neurodegeneration MechanismsNeuroscience8.4%
  3. Adipokines, Inflammation, and Metabolic DiseasesMedicine6.5%
  4. Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology5.8%
  5. COVID-19 Clinical Research StudiesMedicine4.5%
  6. Asthma and respiratory diseasesMedicine4.5%
  7. Gut microbiota and healthBiochemistry, Genetics and Molecular Biology4.5%
  8. T-cell and B-cell ImmunologyImmunology and Microbiology3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
18OpenAlex ·
i10-index
27OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 154 in total · the current year is incomplete

YearArticlesOpen accessCitations
20260024
20250039
20240072
20230078
20224479
202100109

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 6 weeksLetPub ·
Submission to publication (journal-reported)
about 6 weeksDOAJ ·
Peer review
Unspecified peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 1,280NoCC BY
OpenAlexUSD 1,280——
LetPubUSD 1,280No—

Other charges and waivers (author guidelines)

Other fees
No other fees
Page charges
No page charges
Submission fee
No submission fee

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare3 items from the author guidelines
Abstract
≤ 350 words
Keywords
3–10
Templates
Word
Publisher website · model-extracted, each line checked against the text
Article types accepted4
  1. case reportThis journal only accepts original research article, review (includig minireview), and case report.Length not stated
  2. minireviewThis journal only accepts original research article, review (includig minireview), and case report.Length not stated
  3. original research articleThis journal only accepts original research article, review (includig minireview), and case report.Length not stated
  4. reviewThis journal only accepts original research article, review (includig minireview), and case report.Length not stated
Publisher website
Policy excerpts from the journal's websiteOpen access
Open access

No publication fee Model summary

Please note that this journal does not have a publication fee.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Smart Science & Technology LLC
Country or region
United States
Language
English
ISSN
2330-7803
Latest issue on the website
Volume 11 (2024)
Official links

FAQ

Frequently asked questions about Inflammation and Cell Signaling

How long does peer review take at Inflammation and Cell Signaling?

Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Inflammation and Cell Signaling?

According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: 3–10; Templates: Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Inflammation and Cell Signaling based?

Of the 9 board members whose country the journal's board page names, 6 (about 67%) are in mainland China; the countries named most often are Mainland China (6), United States (2) and Sweden (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Inflammation and Cell Signaling?

According to LetPub and DOAJ records, Inflammation and Cell Signaling is indexed in DOAJ.

Is Inflammation and Cell Signaling open access, and what is the APC?

Inflammation and Cell Signaling is a fully open-access journal. APC about USD 1,280.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .